Cargando…

Thromboembolism in Patients with Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disease, which has a marked heterogeneity in clinical expression, natural history, and prognosis. HCM is associated with a high prevalence of thromboembolic events (stroke and systemic embolic events), even if taking no account of atrial fibr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lu, Liu, Zheng, Chen, Xiaoping, He, Sen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797548/ https://www.ncbi.nlm.nih.gov/pubmed/33437207 http://dx.doi.org/10.7150/ijms.50167

Ejemplares similares

Myocardial contraction fraction predicts mortality for patients with hypertrophic cardiomyopathy
por: Liao, Hang, et al.
Publicado: (2020)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

U-shaped association between serum uric acid concentration and mortality in hypertrophic cardiomyopathy patients
por: Wang, Ziqiong, et al.
Publicado: (2020)

Relation between lymphocyte to monocyte ratio and survival in patients with hypertrophic cardiomyopathy: a retrospective cohort study
por: Chen, Zhonglan, et al.
Publicado: (2022)

Assessing the relationship between systemic immune-inflammation index and mortality in patients with hypertrophic cardiomyopathy
por: Wang, Ziqiong, et al.
Publicado: (2021)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Genetic Testing in Patients with Hypertrophic Cardiomyopathy
por: Bonaventura, Jiri, et al.
Publicado: (2021)

Circulating neutrophil extracellular traps in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism
por: Li, Ronald H. L., et al.
Publicado: (2023)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
por: An, Myeonghyun, et al.
Publicado: (2023)

Heart transplantation in patients with hypertrophic cardiomyopathy
por: Torres, Marta Farrero, et al.
Publicado: (2018)

Diagnosis and management of hypertrophic cardiomyopathy
por: Pantazis, Antonis, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy: A Review
por: Houston, Brian A, et al.
Publicado: (2015)

Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy
por: Liao, Hang, et al.
Publicado: (2021)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy
por: Li, Liying, et al.
Publicado: (2023)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Neuromuscular diseases with hypertrophic cardiomyopathy
por: Cesar, Sergi
Publicado: (2018)

Circulating Biomarkers in Hypertrophic Cardiomyopathy
por: Matthia, Eldon L., et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
por: Noureldin, Radwa A, et al.
Publicado: (2012)

Cardiac pacing in patients with hypertrophic obstructive cardiomyopathy
por: Tolosana, José Maria, et al.
Publicado: (2018)

Emerging Medical Treatment for Hypertrophic Cardiomyopathy
por: Argirò, Alessia, et al.
Publicado: (2021)

Hypertrophic cardiomyopathy: The need for randomized trials
por: Olivotto, Iacopo, et al.
Publicado: (2013)

Hypertrophic Cardiomyopathy—Past, Present and Future
por: Liew, Alphonsus C., et al.
Publicado: (2017)

Hypertrophic Cardiomyopathy: An Overview of Genetics and Management
por: Teekakirikul, Polakit, et al.
Publicado: (2019)

Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes
por: Monda, Emanuele, et al.
Publicado: (2022)

Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
por: Litt, Michael J, et al.
Publicado: (2023)

Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies
por: Vio, Riccardo, et al.
Publicado: (2021)

Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy
por: Santoro, Francesco, et al.
Publicado: (2023)

Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
por: Achim, Alexandru, et al.
Publicado: (2023)

Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2023)

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
por: Hong, Ying, et al.
Publicado: (2022)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

The impact of hypertension on the prognosis of patients with hypertrophic cardiomyopathy: a single-center retrospective study
por: Wang, Ziqiong, et al.
Publicado: (2023)

Risk stratification in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2018)

Alcohol septal ablation in hypertrophic cardiomyopathy
por: Mateo, Juan José Santos, et al.
Publicado: (2018)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0kmh3dkc29hq434fdbbf3vqm4i